The fecal mycobiome in patients with Irritable Bowel Syndrome
Abstract Alterations of the gut microbiota have been reported in various gastrointestinal disorders, but knowledge of the mycobiome is limited. We investigated the gut mycobiome of 80 patients with Irritable Bowel Syndrome (IBS) in comparison with 64 control subjects. The fungal-specific internal tr...
Guardado en:
Autores principales: | A. Das, E. O’Herlihy, F. Shanahan, P. W. O’Toole, I. B. Jeffery |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/998ef20184214f3d97b4d2f475745f4c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021) -
An investigation of fecal volatile organic metabolites in irritable bowel syndrome.
por: Iftikhar Ahmed, et al.
Publicado: (2013) -
Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome.
por: Eoin Barrett, et al.
Publicado: (2012) -
Five personality dimensions in patients with irritable bowel syndrome
por: Alireza Farnam, et al.
Publicado: (2008) -
The role of inflammation in irritable bowel syndrome (IBS)
por: Ng QX, et al.
Publicado: (2018)